✦ LIBER ✦

263 A study of capecitabine in elderly patients as first line treatment in advanced or metastatic colorectal cancer

✍ Scribed by J. Feliu; P. Escudero; F. Losa; M. Bolaños; J. Vicent; A. Yubero; J. Sanz-Lacalle; R. López; L. López-Gómez; M. González-Barón

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and bevacizumab as first-li

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Reply: Capecitabine and bevacizumab as f

✍ Feliu, J; Barriuso, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Comment on ‘Capecitabine and bevacizumab

✍ Molina-Garrido, M J; Guillén-Ponce, C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Biweekly XELOX (capecitabine and oxalipl

✍ Grande, Carlos; Quintero, Guillermo; Candamio, Sonia; París Bouzas, Lorena; Vill 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB

669 PUBLICATION Capecitabine and oxalipl

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Phase II study of capecitabine and mitom

✍ Rao, S; Cunningham, D; Price, T; Hill, M E; Ross, P J; Tebbutt, N; Norman, A R; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB